MRPL13 is a Prognostic Cancer Biomarker and Correlates with Immune Infiltrates in Breast Cancer
Zuo Tao,* Huandan Suo,* Lei Zhang, Zining Jin, Zhen Wang, Danyu Wang, Ming Wu, Nanxi Peng, Yujie Zhao, Bo Chen Department of Breast Surgery, The First Hospital of China Medical University, Shenyang, Liaoning Province 110001, People’s Republic of China*These authors contributed equally to t...
Main Authors: | Tao Z, Suo H, Zhang L, Jin Z, Wang Z, Wang D, Wu M, Peng N, Zhao Y, Chen B |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-11-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/mrpl13-is-a-prognostic-cancer-biomarker-and-correlates-with-immune-inf-peer-reviewed-article-OTT |
Similar Items
-
MRPL13 Act as a Novel Therapeutic Target and Could Promote Cell Proliferation in Non-Small Cell Lung Cancer
by: Jing CQ, et al.
Published: (2021-07-01) -
MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer
by: Haoya Xu, et al.
Published: (2021-06-01) -
MRPL13 Promotes Tumor Cell Proliferation, Migration and EMT Process in Breast Cancer Through the PI3K-AKT-mTOR Pathway
by: Cai M, et al.
Published: (2021-02-01) -
Identification of a Three-RNA Binding Proteins (RBPs) Signature Predicting Prognosis for Breast Cancer
by: Yang Liu, et al.
Published: (2021-07-01) -
Prognostic Value and Related Regulatory Networks of MRPL15 in Non-Small-Cell Lung Cancer
by: Yangyang Zeng, et al.
Published: (2021-05-01)